Clinical Trial Update: A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating canagliflozin as add-on therapy to insulin in participants with Type 1 diabetes; the study completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)
• Insulin (insulin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2016-07-18